Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,230,200
-$2,172,560 QoQ
Shares Held
130,000
-28.6% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Mar 31, 2026CallValue
$1,952,400
CallShares
60,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $329,314,446 across 63 Biotechnology names. VKTX ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | IMUX |
Immunic, Inc.
|
2,450,000 | $27,195,000 | |
| 4 | ANAB |
Anaptysbio, Inc
|
625,000 | $23,108,312 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 6 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
590,000 | $19,599,800 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 |
All Filings in VKTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,230,200 | 130,000 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,952,400 | 60,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $6,402,760 | 182,000 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $4,802,070 | 136,500 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $6,307,200 | 240,000 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $2,628,000 | 100,000 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $6,731,000 | 254,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,365,750 | 305,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,267,200 | 280,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,259,200 | 320,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,023,400 | 340,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,110,000 | 355,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,538,200 | 620,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,918,750 | 625,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,401,800 | 580,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,657,000 | 580,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $272,600 | 29,000 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||